tlooto
Sign up
Open AccessMedicine

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

J. Rossouw, G. Anderson, Ross L. Prentice, Andrea Z. LaCroix, C. Kooperberg, Marcia L. Stefanick, R. Jackson, S. A. Beresford, Barbara V. Howard, Karen C. Johnson, J. Kotchen, Judith K. Ockene

2002.7.17JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

DOI: 10.1001/jama.288.3.321

tlooto Summary

Overall health risks exceeded benefits from use of combined estrogen plus progestin for an average 5.2-year follow-up among healthy postmenopausal US women, and the results indicate that this regimen should not be initiated or continued for primary prevention of CHD.

Abstract

Abstract is not available.

Citation format

ROSSOUW, J., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the women's health initiative randomized controlled trial. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 3: 321–33.